Evidence map›Paper›PMID 41159342›Full record

ArticleArchives of Iranian medicine2025

Risk Factors of All-Causes Mortality and

Gholam Reza Sivandzadeh, Sara Shojaei-Zarghani, Seyed Ali Malek-Hosseini, Fardad Ejtehadi, Ramin Niknam, Omid Tarighat, Ali Reza Safarpour

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of Iranian medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gholam Reza SivandzadehGastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID 0000-0001-5461-5754
Sara Shojaei-ZarghaniColorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyed Ali Malek-HosseiniAbu Ali Sina Hospital for Medicine & Organ Transplant, Shiraz University of Medical Sciences, Shiraz, Iran.
Fardad EjtehadiGastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Ramin NiknamGastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Omid TarighatGastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID 0009-0001-9870-8896
Ali Reza SafarpourGastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID 0000-0002-9880-0043

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsThe medical records of 2,600 patients who underwent liver transplantation at Abu-Ali Sina Charity Hospital in Shiraz, Iran, between 2010 and 2023, were evaluated to collect data of eligible patients. Cox proportional hazards regression was used to determine factors affecting mortality and

resultsA total of 419 patients were included. Among them, 127 individuals (30.3%) died and 53 patients (12.6%) received a

conclusionRecipient's age and immunosuppressive regimen are independently associated with mortality and malignancy development following liver transplantation. However, this study is limited by its retrospective design and single-center setting.

Indexed as

Liver TransplantationNeoplasmsPostoperative ComplicationsAdultAgedAge FactorsFemaleHumansImmunosuppressive AgentsIranMaleMiddle AgedProportional Hazards ModelsRetrospective StudiesRisk FactorsSurvival AnalysisImmunosuppressive AgentsLiver transplantationMalignancyMortalitySurvival

Identifiers

PMID41159342
PMCPMC12569993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.